title: Cognitive changes during topiramate therapy.
authors: P
authors: P
authors: Davanzo
authors: E
authors: E
authors: Cantwell
authors: J
authors: J
authors: Kleiner
authors: C
authors: C
authors: Baltaxe
authors: B
authors: B
authors: Najera
authors: G
authors: G
authors: Crecelius
authors: J
authors: J
authors: McCracken
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D001714:Bipolar Disorder / Q000188:drug therapy*; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy*; D003072:Cognition Disorders / Q000139:chemically induced*; D005632:Fructose / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008297:Male; D000077236:Topiramate
chemical_list: D000927:Anticonvulsants; D000077236:Topiramate; D005632:Fructose